Publications by authors named "Andrew Burchat"

Claim this Profile
S
Synthesis and optimization of furano[3,2-d]pyrimidines as selective spleen tyrosine kinase (Syk) inhibitors.
Michael Hoemann, Noel Wilson, Maria Argiriadi, David Banach, Andrew Burchat

Bioorg Med Chem Lett· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor.
Maria A Argiriadi, Eric R Goedken, David Banach, David W Borhani, Andrew Burchat

BMC Struct Biol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thienopyrrole acetic acids as antagonists of the CRTH2 receptor.
Dominique Bonafoux, Ayome Abibi, Brian Bettencourt, Andrew Burchat, Anna Ericsson

Bioorg Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization.
Christopher M Harris, Anna M Ericsson, Maria A Argiriadi, Claude Barberis, David W Borhani, Andrew Burchat

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HTRF-based assay for microsomal prostaglandin E2 synthase-1 activity.
Eric R Goedken, Andrew I Gagnon, Gary T Overmeyer, Junjian Liu, Richard A Petrillo, Andrew F Burchat

J Biomol Screen· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of thienopyridines as Src-family selective Lck inhibitors.
Lily Abbott, Patrick Betschmann, Andrew Burchat, David J Calderwood, Heather Davis

Bioorg Med Chem Lett· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection.
Andrew Burchat, David W Borhani, David J Calderwood, Gavin C Hirst, Biqin Li

Bioorg Med Chem Lett· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck -- a selectivity insight.
Andrew F Burchat, David J Calderwood, Michael M Friedman, Gavin C Hirst, Biqin Li

Bioorg Med Chem Lett· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of (Aminomethyl)stannanes by Reduction of alpha-Amidoorgano Stannanes.
Andrew F. Burchat, J. Michael Chong, Nathan Nielsen

J Org Chem· October 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis